Logo image of BLU

BELLUS HEALTH INC (BLU) Stock Analyst Ratings

USA - Nasdaq - NASDAQ:BLU - CA07987C2040 - Common Stock

14.74 USD
0 (0%)
Last: 6/28/2023, 8:00:02 PM
14.74 USD
0 (0%)
After Hours: 6/28/2023, 8:00:02 PM
Buy % Consensus

76

ChartMill assigns a Buy % Consensus number of 76% to BLU. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 15.39. This target is 4.44% above the current price.
BLU was analyzed by 10 analysts. The buy percentage consensus is at 76. So analysts seem to be have mildly positive about BLU.
In the previous month the buy percentage consensus was at a similar level.
BLU was analyzed by 10 analysts. More opinions would make the average more meaningful.

Related screens

BLU Historical Analyst RatingsBLU Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -76 -69 -62 -55 -48 -41 -34 -27 -20 -13 -6 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 14.7413.3915.0215.3918.56 - -9.18% 1.87% 4.44% 25.90%

Related screens

BLU Current Analyst RatingBLU Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2023-05-15 RBC Capital Reiterate Sector Perform -> Sector Perform
2023-04-19 RBC Capital Downgrade Outperform -> Sector Perform
2023-04-19 Jefferies Downgrade Buy -> Hold
2023-04-18 Evercore ISI Group Downgrade Outperform -> In-Line
2023-03-22 RBC Capital Reiterate Outperform
2023-03-22 HC Wainwright & Co. Reiterate Buy
2022-09-30 RBC Capital Maintains Outperform
2022-09-23 Jefferies Maintains Buy
2022-08-11 HC Wainwright & Co. Maintains Buy
2022-07-13 RBC Capital Maintains Outperform
2022-02-24 HC Wainwright & Co. Maintains Buy
2021-12-13 Evercore ISI Group Maintains Outperform
2021-12-07 RBC Capital Maintains Outperform
2021-10-18 RBC Capital Maintains Outperform
2021-09-14 HC Wainwright & Co. Maintains Buy
2021-08-12 RBC Capital Initiate Outperform

BELLUS HEALTH INC / BLU FAQ

Can you provide the average price target for BELLUS HEALTH INC stock?

10 analysts have analysed BLU and the average price target is 15.39 USD. This implies a price increase of 4.44% is expected in the next year compared to the current price of 14.74.


Can you provide the consensus rating for BELLUS HEALTH INC stock?

The consensus rating for BELLUS HEALTH INC (BLU) is 76 / 100 . This indicates that analysts generally have a positive outlook on the stock.


What is the number of analysts for BLU stock?

The number of analysts covering BELLUS HEALTH INC (BLU) is 10.